SLC5A2 and diabetes mellitus: Treatments such as immunosuppressive drugs, which are administered to kidney transplant (KT) patients, or sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially used to treat diabetes, can significantly contribute to Mg homeostasis, at least at the circulating levels [17].